Robot-Assisted Urologic Cancer Surgery: Current Standards and Future Trends

A special issue of Current Oncology (ISSN 1718-7729).

Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 1858

Special Issue Editors


E-Mail Website
Guest Editor
Hospital Clínico San Carlos de Madrid, Madrid, Spain
Interests: urological oncology; laparoscopy and robotics; kidney transplant
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Hospital Clínico San Carlos, Universidad Complutense de Madrid, Madrid, Spain
Interests: urological oncology; functional and female urology; robotics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The field of robotic surgery has grown exponentially over the last decade. The number and availability of robotic systems indicate a significant trend in its increasing dissemination and routine use. With the aim of ensuring that surgeries become more precise, standardized, and efficient, surgical robots are being adopted in almost every field of surgery. This success translates into the “democratization” of surgery in healthcare systems in which the skills of the physician are enhanced via a smoother learning curve, thus resulting in a more uniform technique being delivered to all patients with excellent results. Future improvements will have the potential to promote robotic surgery into becoming the gold standard of minimally invasive surgery. This Special Issue aims to present a collection of experiences from around the globe on robotic surgery, new systems, and future trends.

Original research articles and reviews are welcome for submission to this Special Issue. Research areas to be covered may include (but are not limited to) the following: procedures due to urological–oncological conditions (bladder, kidney, prostate, retroperitoneum, etc.), future trends such as 3D reconstruction, augmented reality, and artificial intelligence, among others.

We look forward to receiving your contributions.

You may choose our Joint Special Issue in Cancers.

Dr. Juan Gómez Rivas
Prof. Dr. Jesús Moreno-Sierra
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prostate
  • bladder
  • kidney
  • retroperitoneum
  • urology
  • robotics
  • oncology
  • surgery

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

10 pages, 5533 KiB  
Case Report
One-Step Robot-Assisted Complete Urinary Tract Extirpation in Man with End-Stage Renal Disease on Dialysis: The First Case Report
by Che-Hsueh Yang, Chao-Yu Hsu, Yi-Sheng Lin, Min-Che Tung and Yen-Chuan Ou
Curr. Oncol. 2023, 30(5), 5093-5102; https://doi.org/10.3390/curroncol30050385 - 16 May 2023
Viewed by 1559
Abstract
Urothelial carcinoma (UC) could be observed in urinary bladder (UBUC) and upper urinary tracts (UTUC). In the National Comprehensive Cancer Network guidelines for bladder cancer, extirpative surgery is indicated in certain cases. However, some extreme cases might also need the extirpation of the [...] Read more.
Urothelial carcinoma (UC) could be observed in urinary bladder (UBUC) and upper urinary tracts (UTUC). In the National Comprehensive Cancer Network guidelines for bladder cancer, extirpative surgery is indicated in certain cases. However, some extreme cases might also need the extirpation of the majority of the urinary tract, which is called complete urinary tract extirpation (CUTE). We present a patient diagnosed with high-grade UBUC and UTUC. He underwent dialysis for end-stage renal disease (ESRD) at the same time. Considering his non-functional kidneys and removing his high-risk urothelium at the same time, we performed robot-assisted CUTE to extirpate both his upper urinary tracts, urinary bladder, and prostate. In our experience, the console time was not significantly elongated, and the perioperative course was uneventful. To our knowledge, this is the first case report adopting a robotic system in such an extreme case. We conclude that robot-assisted CUTE is worth further study regarding its oncological survival outcomes and perioperative safety in patients with ESRD on dialysis. Full article
Show Figures

Figure 1

Back to TopTop